Selarsdi (ustekinumab-aekn) injection for subcutaneous use is for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis.
inVio Health Network and CVS Health’s Accountable Care Organization are partnering on a program aimed at improving the quality and health of 60,000 Medicare beneficiaries.